Capillary zone electrophoresis-mass spectrometry (CZE-MS)
has been
recognized as a valuable technique for the proteomics of mass-limited
biological samples (i.e., single cells). However, its broad adoption
for single cell proteomics (SCP) of human cells has been impeded by
the low sample loading capacity of CZE, only allowing us to use less
than 5% of the available peptide material for each measurement. Here
we present a reversed-phase-based solid-phase microextraction (RP-SPME)-CZE-MS
platform to solve the issue, paving the way for SCP of human cells
using CZE-MS. The RP-SPME-CZE system was constructed in one fused
silica capillary with zero dead volume for connection via in situ
synthesis of a frit, followed by packing C8 beads into the capillary
to form a roughly 2 mm long SPME section. Peptides captured by SPME
were eluted with a buffer containing 30% (v/v) acetonitrile and 50
mM ammonium acetate (pH 6.5), followed by dynamic pH junction-based
CZE-MS. The SPME-CZE-MS enabled the injection of nearly 40% of the
available peptide sample for each measurement. The system identified
257 ± 24 proteins and 523 ± 69 peptides (N = 2) using a Q-Exactive HF mass spectrometer when only 0.25 ng of
a commercial HeLa cell digest was available in the sample vial and
0.1 ng of the sample was injected. The amount of available peptide
is equivalent to the protein mass of one HeLa cell. The data indicate
that SPME-CZE-MS is ready for SCP of human cells